Endocrinology News and Research

Latest Endocrinology News and Research

NCDP to help bring dramatic improvement in the prevention and care of diabetes

The American Clinical Laboratory Association's Results for Life Campaign (RFL) today recognized the National Changing Diabetes Program (NCDP) for funding a newly published study on quality measurement in diabetes care.

30 Oct 2009

Healthy eating tips for diabetics

A new case of diabetes strikes every 20 seconds. With nearly 24 million Americans of all ages affected by the disease and an additional 57 million at risk for diabetes, diabetes has reached epidemic proportions.(1) If current trends continue, one out of three children will live with diabetes sometime in their future.

30 Oct 2009

Researchers use BEZ235 drug to eliminate NSCL cancer

Researchers at UT Southwestern Medical Center have eliminated non-small cell lung (NSCL) cancer in mice by using an investigative drug called BEZ235 in combination with low-dose radiation.

30 Oct 2009

Diabetes may damage nerves in the skin leading to dry skin, say experts

As American Diabetes Month approaches, leading experts like Dr. Jacqueline Sutera, DPM, stress the importance of foot care, especially for those with diabetes. People with diabetes are at a greater risk of developing dry skin due to nerve damage.

30 Oct 2009

Risk of serious flu-related sickness far outpaces risk of injectable vaccine in pregnant women

Pregnant women who catch the flu are at serious risk for flu-related complications, including death, and that risk far outweighs the risk of possible side effects from injectable vaccines containing killed virus, according to an extensive review of published research and data from previous flu seasons.

30 Oct 2009

NIH launches randomized trail to determine whether lower BP goal cuts the risk of heart and kidney diseases

The National Institutes of Health is launching a large multicenter randomized clinical trial to determine whether maintaining blood pressure levels lower than current recommendations further reduces the risk of cardiovascular and kidney diseases, or age-related cognitive decline.

30 Oct 2009

Aerobics and resistance training exercise prevent visceral fat gain

A study conducted by exercise physiologists in the University of Alabama at Birmingham (UAB) Department of Human Studies finds that as little as 80 minutes a week of aerobic or resistance training helps not only to prevent weight gain, but also to inhibit a regain of harmful visceral fat one year after weight loss.

30 Oct 2009

Vitamin D deficiency may account for increased risk of end-stage renal disease in African Americans

Low levels of vitamin D may account for nearly 60 percent of the elevated risk of end-stage renal disease (ESRD) in African Americans, according to a report in the December Journal of the American Society of Nephrology (JASN).

30 Oct 2009

AstraZeneca bolsters revenue with Toprol-XL and H1N1 vaccine sales

AstraZeneca, Third quarter revenue increased by 10 percent at constant exchange rates (CER) to $8,200 million.

29 Oct 2009

CCS updates the Canadian guidelines for the management and treatment of dyslipidemia

The management of dyslipidemia continues to evolve and despite improvements in recurrent cardiovascular events and a decrease in cardiac mortality, cardiovascular disease (CVD) still represents the major burden of disease in this country.

29 Oct 2009

Third-quarter fiscal 2009 results announced by Endo Pharmaceuticals

Endo Pharmaceuticals today reported financial results for the third quarter of 2009.

29 Oct 2009

Ipsen announces sales highlights for the first nine months of 2009

Ipsen reported its sales for the third quarter and first nine months of 2009.

29 Oct 2009

Raise awareness about psoriasis: National Psoriasis Foundation's call to psoriasis affected Americans

Today is World Psoriasis Day and the National Psoriasis Foundation is asking all Americans affected by psoriasis and psoriatic arthritis to raise awareness about these diseases by going to www.psoriasis.org/wpd and taking action.

29 Oct 2009

CytRx study reveals potential of molecular chaperones in design of anti-aging pharmaceuticals

CytRx Corporation, a biopharmaceutical company and a leader in molecular chaperone regulation technology, today announced that a paper published in the peer-reviewed journal Gerontology concluded that molecular chaperone amplification may represent a “significant strategy” in the future design of anti-aging pharmaceuticals.

29 Oct 2009

Drug delivery device companies need to rethink their strategies to remain competitive

With increasing decentralization, new cell, gene and RNAI therapies, and a growing emphasis on patient self-care, many drug delivery device companies will need to rethink their strategies in order to remain competitive.

29 Oct 2009

NIEHS supports research to study the potential effects of BPA on human health

Researchers studying the health effects of the chemical bisphenol A (BPA) gathered in North Carolina to launch an integrated research initiative to produce data that will allow for a comprehensive assessment of its possible human health effects.

29 Oct 2009

Treatment plan can benefit both doctor and patient

Jeff Gavin's diagnosis of leukemia last year threw him into a new world. Suddenly the father of five had to keep track of a bevy of new medicines and maintain a complicated series of appointments and hospital visits for chemotherapy.

29 Oct 2009

Roche discloses the results of first Phase III clinical study using Taspoglutide

Ipsen (Paris:IPN), an innovation-driven global specialty pharmaceutical group, today announced that its partner Roche has disclosed the results of a first phase III clinical study using Taspoglutide, the first human once weekly glucagon-like peptide-1 (GLP-1) analogue originating from Ipsen’s Research.

29 Oct 2009

Dysport drug for treatment of cervical dystonia launched in the United States

Ipsen, an innovation-driven global specialty pharmaceutical group, today announced that Dysport® is now available in the United States for the treatment of cervical dystonia in adults.

29 Oct 2009

Impact of wellness programs on pharmaceutical, diagnostic and device markets

MarketResearch.com has announced the addition of Kalorama Information's new report, "The Market for Wellness Programs and Their Impact on Pharmaceutical, Diagnostic and Device Product Markets," to their collection of Healthcare market reports.

29 Oct 2009

Endocrinology News and Research

Latest Endocrinology News and Research

NCDP to help bring dramatic improvement in the prevention and care of diabetes

Healthy eating tips for diabetics

Researchers use BEZ235 drug to eliminate NSCL cancer

Diabetes may damage nerves in the skin leading to dry skin, say experts

Risk of serious flu-related sickness far outpaces risk of injectable vaccine in pregnant women

NIH launches randomized trail to determine whether lower BP goal cuts the risk of heart and kidney diseases

Aerobics and resistance training exercise prevent visceral fat gain

Vitamin D deficiency may account for increased risk of end-stage renal disease in African Americans

AstraZeneca bolsters revenue with Toprol-XL and H1N1 vaccine sales

CCS updates the Canadian guidelines for the management and treatment of dyslipidemia

Third-quarter fiscal 2009 results announced by Endo Pharmaceuticals

Ipsen announces sales highlights for the first nine months of 2009

Raise awareness about psoriasis: National Psoriasis Foundation's call to psoriasis affected Americans

CytRx study reveals potential of molecular chaperones in design of anti-aging pharmaceuticals

Drug delivery device companies need to rethink their strategies to remain competitive

NIEHS supports research to study the potential effects of BPA on human health

Treatment plan can benefit both doctor and patient

Roche discloses the results of first Phase III clinical study using Taspoglutide

Dysport drug for treatment of cervical dystonia launched in the United States

Impact of wellness programs on pharmaceutical, diagnostic and device markets

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Endocrinology News and Research

Latest Endocrinology News and Research

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Newsletters you may be interested in